Visioneering Technologies Inc (VTI) - Product Pipeline Analysis, 2020 Update
Visioneering Technologies Inc (VTI) is a medical device company that offers ophthalmic solutions. It develops a portfolio of technologies to address eye care issues such as presbyopia, myopia and astigmatism. Its technology includes myopia correction technology, silicone hydrogel material platform and intraocular lens technology. VTI offers products such as multifocal lens and sphere lens for presbyope and myopia correction. It conducts market research in the areas of contact lens consumer study, eye care practitioner study, multifocal lens market opportunity and multifocal lens potential, among others. The company’s optical designs for contact lenses and in-eye products will provide solutions to under-penetrated market. VTI is headquartered in Alpharetta, Georgia, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Visioneering Technologies Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Visioneering Technologies Inc Company Overview
Visioneering Technologies Inc Company Snapshot
Visioneering Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
Visioneering Technologies Inc – Pipeline Analysis Overview
Visioneering Technologies Inc - Key Facts
Visioneering Technologies Inc - Major Products and Services
Visioneering Technologies Inc Pipeline Products by Development Stage
Visioneering Technologies Inc Ongoing Clinical Trials by Trial Status
Visioneering Technologies Inc Pipeline Products Overview
Contact Lens
Contact Lens Product Overview
Intraocular Lens
Intraocular Lens Product Overview
NaturalVue (etafilcon A) Multifocal 1 Day Contact Lens
NaturalVue (etafilcon A) Multifocal 1 Day Contact Lens Product Overview
NaturalVue (etafilcon A) Multifocal 1 Day Contact Lens Clinical Trial
NaturalVue (etafilcon A) Sphere 1 Day Contact Lenses
NaturalVue (etafilcon A) Sphere 1 Day Contact Lenses Product Overview
NaturalVue Toric 1 Day Contact Lenses
NaturalVue Toric 1 Day Contact Lenses Product Overview
NaturalVue Toric Multifocal 1 Day Contact Lenses
NaturalVue Toric Multifocal 1 Day Contact Lenses Product Overview
VTI MPC Lens
VTI MPC Lens Product Overview
Visioneering Technologies Inc - Key Competitors
Visioneering Technologies Inc - Key Employees
Visioneering Technologies Inc - Locations And Subsidiaries
Head Office
Recent Developments
Visioneering Technologies Inc, Recent Developments
Sep 07, 2020: Visioneering sees continued recovery
Jul 15, 2020: Visioneering Technologies : Change of company secretary & registered address
Feb 06, 2020: Mature presbyopes clinical research update presented at Global Specialty Lens Symposium (GSLS)
Feb 04, 2020: Visioneering Technologies achieves first sale in Singapore as Asian expansion accelerates
Nov 17, 2019: Visioneering continues Asia expansion with registration achieved in Singapore
Oct 25, 2019: The Science Behind NaturalVue’s Neurofocus Optics Technology presented at American Academy of Optometry
Oct 15, 2019: Craig Johnson has joined Visioneering Technologies as quality specialist
Sep 30, 2019: Visioneering enters European sales and distribution agreement with Menicon, Japan’s largest contact lens company
Aug 05, 2019: Suzette Tineo to lead territory management efforts for NaturalVue Contact Lenses in Los Angeles
Jul 24, 2019: Visioneering expands into Asia with securing of regulatory registration in Hong Kong
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List Of Tables
Visioneering Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
Visioneering Technologies Inc Pipeline Products by Equipment Type
Visioneering Technologies Inc Pipeline Products by Indication
Visioneering Technologies Inc Ongoing Clinical Trials by Trial Status
Visioneering Technologies Inc, Key Facts
Visioneering Technologies Inc, Major Products and Services
Visioneering Technologies Inc Number of Pipeline Products by Development Stage
Visioneering Technologies Inc Pipeline Products Summary by Development Stage
Visioneering Technologies Inc Ongoing Clinical Trials by Trial Status
Visioneering Technologies Inc Ongoing Clinical Trials Summary
Contact Lens - Product Status
Contact Lens - Product Description
Intraocular Lens - Product Status
Intraocular Lens - Product Description
NaturalVue (etafilcon A) Multifocal 1 Day Contact Lens - Product Status
NaturalVue (etafilcon A) Multifocal 1 Day Contact Lens - Product Description
NaturalVue (etafilcon A) Multifocal 1 Day Contact Lens - Myopia Progression in Children and Adolescents Before and after Use of a Novel Extended Depth of Focus Daily Disposable Soft Contact Lens
NaturalVue (etafilcon A) Sphere 1 Day Contact Lenses - Product Status
NaturalVue (etafilcon A) Sphere 1 Day Contact Lenses - Product Description
NaturalVue Toric 1 Day Contact Lenses - Product Status
NaturalVue Toric 1 Day Contact Lenses - Product Description
NaturalVue Toric Multifocal 1 Day Contact Lenses - Product Status
NaturalVue Toric Multifocal 1 Day Contact Lenses - Product Description
VTI MPC Lens - Product Status
VTI MPC Lens - Product Description
Visioneering Technologies Inc, Key Employees
Glossary
List Of Figures
Visioneering Technologies Inc Pipeline Products by Equipment Type
Visioneering Technologies Inc Pipeline Products by Development Stage
Visioneering Technologies Inc Ongoing Clinical Trials by Trial Status
Visioneering Technologies Inc (VTI) - Product Pipeline Analysis, 2019 Update
Visioneering Technologies Inc (VTI) - Product Pipeline Analysis, 2019 Update
USD 750 View ReportVisioneering Technologies Inc - Product Pipeline Analysis, 2017 Update
Visioneering Technologies Inc (VTI) is a medical device company that develops and commercializes on-eye and in-eye solutions for presbyopia, astigmatism and myopia progression control. The company offers technology consists of
USD 750 View ReportMind Technologies Inc (MIND) - Financial and Strategic SWOT Analysis Review
MIND Technologies Inc (MIND) is a diversified company. The company designs, manufactures and markets marine sonar and seismic equipment, exploration equipment and specialized equipment. It offers seismic source acquisition and
USD 300 View ReportTheralink Technologies Inc (OBMP) - Financial and Strategic SWOT Analysis Review
Theralink Technologies Inc (Theralink), formerly OncBioMune Pharmaceuticals Inc is a biopharmaceutical company that develops novel cancer immunotherapy products. The companys products comprise biosimilars and vaccines developed for cancer types such
USD 300 View ReportFill The Form For Sample Request